Experience unparalleled efficiency and customization with our pig antibody library for phage display, dedicated to addressing your unique research needs. With over 300+ successful antibody phage display projects completed, you can rest assured that our expertise and track record position us to exceed your expectations in custom monoclonal porcine (pig) antibody production. We prioritize your time with rapid delivery, ensuring you receive three unique antibodies in just 7 weeks. Each antibody delivered is highly customizable ensuring superior adaptability for your research or medical pursuits. ProteoGenix’s unique pig monoclonal antibody phage library is where efficiency, diversity, and customization converge to empower your success. Schedule a free quote and consultation with one of our service experts today!

ProteoGenix’s Pig Antibody Discovery Platform

Antigen procurement or design

Your pig-specific antigen can either be:

  • Delivered to ProteoGenix or
  • Engineered by ProteoGenix (preferred)

Library Screening and Biopanning

  • Identify antibody candidates from pre-built naive libraries (Fab and scFv)
  • 4-6 rounds of biopanning, a method that screens cat antigen-binding phages.

ELISA Screening of Single Phage Binders

  • Further validate binders by ELISA screening until at least 3-10 different binders have been identified.

DNA Extraction & Antibody Sequencing

  • The antibody DNA sequences from inside each phage are sequenced and at least 3 unique binders are identified

What Are the Advantages of a Pig Monoclonal Antibody Library?

ProteoGenix has pioneered an advanced phage display platform, ensuring the generation of high-quality pig monoclonal antibodies. Leveraging our expertise in phage display library construction, we harvest whole blood samples from immunized pigs (custom immune library) or naïve pigs (naïve library) and PCR amplify the antibody repertoire. The result? A swine antibody library with a potential diversity of up to 1010 antibody clones for custom immune pig libraries and up to 109 pig antibody clones for naïve libraries.

In the realm of precision research, diagnosis, and treatment of specific pig diseases, our pig monoclonal antibody phage display library emerges as an indispensable tool. Just as with human therapeutic antibodies, isolating pig monoclonal antibodies for therapeutic use necessitates the use of a pig-specific phage display library, avoiding harmful immune reactions. Other advantages include:


  • Pig-Specific Research:
    Enables focused investigation into pig-specific diseases, immune responses, and physiological processes, contributing to a deeper understanding of pig biology.


  • Therapeutic Antibody Development:
    Facilitates the identification and selection of antibodies with therapeutic potential, allowing the development of novel treatments for infectious diseases, immune disorders, and other health conditions in pigs.


  • Diversity and Specificity:
    Provides a diverse repertoire of antibodies, allowing researchers to target a wide range of pig antigens with high specificity.


  • Phage Display Technology:
    Utilizes phage display technology for the efficient screening and isolation of antibodies, offering a rapid and effective method for antibody discovery.


  • Customization and Flexibility:
    Additional services allow for the customization of antibodies to meet specific research or therapeutic requirements.


  • Rapid Delivery :
    Streamlines the antibody discovery process, with the potential for rapid delivery of antibodies in a matter of weeks.


  • Epitope Diversity :
    The library may contain antibodies targeting different epitopes including toxins and antigens with low immunogenicity, enhancing the breadth of therapeutic potential


  • Ethical Sourcing:
    Supports ethical practices by offering animal-free methods for antibody generation, aligning with the highest ethical standards in research.


  • Application in Various Fields :
    Applicable in diverse fields such as veterinary medicine, agriculture, and infectious disease research, showcasing versatility in addressing a range of scientific and medical challenges.

Which Ethical Advantages for using Pig Antibody Phage Display Libraries rather than Traditional Pig Antibody Production Methods?

The utilization of pig antibody libraries generated for phage display, offers several ethical advantages compared to other pig antibody production methods such as single B cell sreening or hybridomas. These include:


  • Reduced Animal Distress:
    Phage display-based Pig Antibody Libraries eliminate the need for repeated immunizations of live animals, minimizing distress and discomfort for pigs.


  • No Sacrifice for Antibody Retrieval:
    Libraries generated through phage display do not require the sacrifice of animals for antibody retrieval, avoiding invasive procedures and ethical concerns associated with traditional methods.


  • Synthetic Sources and In Vitro Generation:
    Phage display allows the creation of libraries from synthetic or in vitro sources, reducing reliance on live animals and eliminating the need for invasive procedures in antibody production.


  • Diverse Antibodies without Large-Scale Immunization:
    The diversity of antibodies obtained through phage display enables the selection of high-affinity antibodies without the necessity of large-scale pig immunization, minimizing the impact on pig populations.


  • Alignment with Ethical Principles :
    The adoption of Pig Antibody Libraries, particularly through phage display methods, reflects a commitment to ethical research practices by reducing the overall impact on live animals while advancing scientific discovery and therapeutic development.


Pig Antibodies: Versatile applications in Research, Veterinary Medicine, and Industry Enhancement

Pig antibody libraries serve as versatile tools with applications spanning various domains, from research to diagnostics and therapeutic development. These libraries, rich in pig-specific antibodies, offer unprecedented opportunities for advancing our understanding of pig biology and addressing health challenges in swine populations.

Pig Monoclonal Antibodies in Research

Custom pig-specific monoclonal antibodies play a crucial role in advancing porcine veterinary research. Tailored to target pig antigens, these antibodies open new avenues in pig-specific studies including,

  • Targeted Disease Exploration :
    Custom pig-specific monoclonal antibodies aid in the investigation of pig-specific diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS).


  • Vaccine Development:
    Crucial role in studying and combating infectious diseases like swine influenza. Moreover, it contributes to the creation of more effective preventive treatments in pigs.


  • Xenotransplantation Research:
    Contributes to understanding the immunological aspects of pig-to-human organ transplantation.


  • Tailored Precision:
    Indispensable in porcine veterinary research, opening new avenues for scientific exploration.


Whether exploring immunology, biochemistry, cancer biology, diagnostic, or therapeutic use, the specificity and reliability of custom pig-specific monoclonal antibodies isolated from monoclonal porcine (pig) antibody libraries provide researchers with a valuable resource to enhance the accuracy and depth of their experimental or medical applications.

Pig Monoclonal Antibodies in Veterinary Medicine

Tailored to recognize pig antigens, porcine monoclonal antibodies can be employed for various therapeutic applications. The species specificity of pig antibodies is crucial when considering the pigs immune system will attack non-pig antibodies. This may inadvertently activate the pig’s immune response resulting in dangerous immune reactions or reduced efficacy.

By utilizing pig-specific antibodies, the risk of such unwanted immune responses is minimized, allowing for safe and efficient immunotherapeutics. This targeted approach not only enhances the therapeutic outcomes but also represents a pivotal advancement in veterinary medicine, promoting optimal health and well-being in pig populations.

Porcine Antibody Library for Phage Display, Use in the Swine Industry and Pig Farming

Pig antibodies play a vital role in enhancing the overall health and disease resistance of pigs, leading to improvements in pork production and safety for consumers. Here’s how the manipulation of the immune system, including the use of pig antibodies, contributes to decreasing infectious diseases in pigs:

  • Vaccination and Immunomodulation:
    Vaccination Strategies: By leveraging porcine antibodies, targeted vaccination programs can be developed to stimulate a robust immune response in pigs. This can include the production of specific antibodies against key pathogens.
    Immunomodulators: Immunomodulators, substances that modify the immune response, can be utilized to enhance the efficacy of vaccines. Monoclonal porcine (pig) antibodies can be engineered or manipulated to act as immunomodulators, contributing to a more potent and tailored immune defense in pigs.


  • Recognition of Immune Response Alterations:
    Pathogen-Induced Changes: Understanding how pathogens like Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and classical swine fever alter the immune response is crucial. Pig antibodies can aid in recognizing and targeting specific antigens associated with these pathogens.
    Disease Management: By comprehending the immune response alterations induced by infectious agents, effective disease management strategies can be implemented. This includes the development of diagnostic tools that utilize monoclonal porcine (pig) antibodies to detect and monitor diseases.


  • Improvements in Disease Management:
    Precision Medicine: Tailoring interventions based on the specific immune responses of individual pigs becomes possible with the use of pig antibodies. This precision approach allows for more targeted disease management and treatment strategies.
    Preventive Measures: Proactive measures, such as vaccination campaigns supported by swine antibodies, contribute to preventing the spread of infectious diseases within pig populations. This leads to a healthier herd.


  • Enhancements in Pork Meat Quality and Safety:
    Reduced Disease Impact: Decreasing infectious diseases in pigs not only improves their overall health but also minimizes the impact of diseases on meat quality. Healthier pigs are more likely to yield higher-quality pork products for consumers.
    Food Safety Assurance: With effective disease management using pig antibodies, the risk of pathogens entering the food supply chain is reduced. This contributes to enhanced food safety standards in pork products.

The Edge of Pig Antibody Phage Display Over Traditional Approaches

Pig antibody libraries generated through phage display offer advantages in terms of diversity, speed, scalability, directed evolution, rare antibody isolation, conservation of native pairings, flexibility, and cost-effectiveness. These advantages make phage display a powerful and efficient tool for the discovery and development of pig antibodies for various research, diagnostic, and therapeutic applications. Here are a few examples:

  • Diversity and Coverage:
    Phage display allows for the generation of highly diverse pig antibody libraries, covering a broad range of antigens. This diversity is essential for capturing a wide spectrum of targets, enabling the identification of antibodies with various specificities.


  • Rapid Antibody Discovery:
    Phage display facilitates rapid antibody discovery. Screening large libraries against specific antigens can lead to the identification of high-affinity monoclonal pig antibodies in a shorter timeframe compared to traditional methods, expediting the antibody development process.


  • High-Throughput Screening:
    Phage display enables high-throughput screening of pig antibody libraries. This automated and scalable approach allows for the simultaneous screening of numerous antibodies against multiple targets, enhancing the efficiency of antibody discovery campaigns.


  • Directed Evolution for Affinity Maturation:
    Phage display allows for directed evolution, enabling the optimization of antibody affinities. Iterative rounds of selection and amplification can be performed to evolve pig antibodies with improved binding characteristics, a process challenging to achieve with traditional methods.


  • Isolation of Rare Antibodies:
    Phage display enables the isolation of rare antibodies. By screening large libraries, even antibodies present in low frequencies can be identified, providing access to a diverse pool of antibodies that may possess unique or rare specificities.


  • Antibodies Targeting Antigens that are Toxic or Have Low Immunogenicity:
    Antibody phage display does not require pig immunization with the target antigen unlike B cell sorting or the hybridoma method. Therefore, antigens such as toxins, venoms, or those that elicit a poor immune response are excellent antibody phage display candidates.


  • Conservation of Native Pairings:
    Phage display preserves the native pairing of heavy and light chains in antibodies. This is critical for maintaining the natural antibody structure and function, ensuring that the isolated antibodies closely resemble the in vivo immune response in pigs.


  • Flexible Library Construction:
    Phage display allows for flexibility in swine antibody library construction. Libraries can be tailored to focus on specific antibody isotypes, subclasses, or regions of interest, providing control and customization in the antibody discovery process.


  • Cost-Effectiveness:
    Phage display offers cost-effective antibody discovery. The high-throughput nature of phage display reduces the overall cost per identified antibody, making it an efficient and economical method for generating pig antibodies compared to traditional approaches.

What Are the Different Applications of Pig Antibody Libraries?

Pig antibody libraries serve as versatile tools with applications spanning various domains, from research to diagnostics and therapeutic development. These libraries, rich in pig-specific antibodies, offer unprecedented opportunities for advancing our understanding of pig biology and addressing health challenges in swine populations.

  • Research:
    Example: Pig monoclonal antibodies can be employed in research to study specific pig antigens. For instance, a research project may focus on elucidating immune responses in pigs during infection, utilizing pig monoclonal antibodies to identify and characterize immune markers.
  • Diagnostics:
    Example: In diagnostic applications, pig monoclonal antibodies can be used to develop sensitive and specific detection assays. For instance, antibodies targeting unique pig biomarkers could enhance the accuracy of diagnostic tests for swine diseases, improving early detection and management.
  • Therapeutic Development:
    Example: Pig monoclonal antibodies may play a crucial role in therapeutic development. For example, antibodies targeting specific cancer-related antigens in pigs could be explored for the development of immunotherapies, offering potential treatments for pig health and laying the groundwork for analogous human therapies.

Pig Monoclonal Antibodies vs Human Monoclonal Antibodies

Pig monoclonal antibodies have many similarities compared to humans. This makes pigs suitable for biomedical research, vaccine development, drug testing, disease modeling, and organ transplant research. Below is a table comparing and contrasting human and pig antibody repertoires:

Antibody Features Human Antibodies Porcine Antibodies
Antibody Classes IgM, IgD, IgG, IgE, IgA IgM, IgD, IgG, IgE, IgA (larger IgG subclass diversity in pigs)
VH Gene Family Various VH gene families Predominantly VH3 family in pigs
Junctional Diversity Present Present
IgG Subclass Varied Larger IgG subclass diversity in pigs
VH Gene Usage Varied Few predominant VH genes in pigs
DH and JH Segment Usage Varied Primarily two DH segments and one JH in pigs
Light Chain Usage Kappa and lambda chains Distinct proportional light chain usage in pigs (different from rodents)

The diversity in antibody classes, such as IgM, IgD, IgG, IgE, and IgA, in both human and porcine antibodies, underscores their versatility in addressing different types of antigens and immune responses. Larger IgG subclass diversity in pigs is particularly valuable in applications requiring a broad range of diverse IgG antibodies, increasing the probability of obtaining high-affinity candidates.

Additionally, variations in VH gene families, junctional diversity, and light chain usage highlight a comprehensive immune response to antigens. Junctional diversity, involving the variability in connecting segments, enhances the antibodies’ ability to target a wide range of epitopes. Recognizing the importance of these similarities enhances our ability to harness the unique strengths of human and porcine antibodies for advanced research, diagnostics, and therapeutic development.

Pioneering Progress: Pigs as Essential Models in Advancing Human Medicine

Pigs are crucial animal models in human medicine due to their physiological similarities to humans, enabling realistic studies of diseases, drug responses, and medical interventions. Their analogous anatomy, size, and organ systems make pigs invaluable for preclinical research, providing insights that significantly contribute to the development and testing of therapies, medical devices, and treatments, ultimately advancing our understanding of human health. Below are a few examples of how pigs have advanced human medicine:

Application of Pig Animal Models Description
Human Health Issues Pigs serve as excellent animal models, addressing various human health issues. Their similarities with humans make them valuable for experimental studies related to human health such as cardiovascular, respiratory, and digestive system studies.
Medical Skill Education Pigs are utilized for medical skill education, providing a realistic and applicable model for training purposes such as surgical training, endoscopy training, and anesthesia and intubation training
Development of New Devices In the field of medical device development, pigs offer a relevant model for testing and refining new devices, ensuring their efficacy and safety in a system that closely mirrors human physiology such as cardiac devices, orthopedic implants, and endoscopic instruments.
Therapeutic Strategies Pig animal models contribute to the development and testing of therapeutic strategies. Their use allows researchers to assess the effectiveness of new treatments before moving to clinical trials, potentially accelerating the translation of therapies to humans such as cardiovascular therapies and infectious disease therapies.
Transplantation Research Pigs have played a crucial role in transplantation research. Successful outcomes in cardiovascular clinical work and advancements in stem cell therapies showcase the relevance of pig models in understanding the transplantation processes.
Cardiovascular Clinical Work Pig animal models have demonstrated success in cardiovascular clinical work, providing insights and advancements that contribute to our understanding of cardiovascular diseases and potential treatments.
Stem Cell Therapies Pigs have been utilized in stem cell therapies, highlighting their importance in advancing regenerative medicine. The use of pig models in this context enables researchers to explore the potential applications and limitations of stem cell-based treatments.
Bacterial, Viral, Cancer, and Inflammatory Disease Research Pig models have been instrumental in translational research related to bacterial, viral, cancer, and inflammatory diseases. The anatomical and histological similarities between pigs and humans make them valuable for studying these diverse health conditions.